NASDAQ:CRVS

Corvus Pharmaceuticals SEC Filings & 10K Form

$2.16
-0.09 (-4.00 %)
(As of 07/26/2021 11:47 AM ET)
Add
Compare
Today's Range
$2.14
$2.24
50-Day Range
$2.18
$2.84
52-Week Range
$2.07
$5.74
Volume4,760 shs
Average Volume575,686 shs
Market Capitalization$82.75 million
P/E RatioN/A
Dividend YieldN/A
Beta1.66

Corvus Pharmaceuticals (NASDAQ:CRVS) SEC Filings

DateFilerForm TypeView
06/16/2021
3:19 PM
Corvus Pharmaceuticals (Issuer)
Mitchell Edith P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:19 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:18 PM
CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:17 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:16 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:15 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:15 PM
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:05 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2021
3:27 PM
Corvus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/20/2021
4:02 PM
Corvus Pharmaceuticals (Filer)
Form DEFA14A
04/20/2021
3:49 PM
Corvus Pharmaceuticals (Filer)
Form DEF 14A
03/25/2021
8:18 AM
Corvus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2021
7:31 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2021
3:52 PM
Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:47 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:44 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:13 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
8:18 PM
Corvus Pharmaceuticals (Subject)
MILLER RICHARD A MD (Filed by)
Form SC 13G/A
02/12/2021
8:00 AM
Corvus Pharmaceuticals (Filer)
Form 424B5
02/11/2021
4:14 PM
Corvus Pharmaceuticals (Filer)
Form 424B5
02/11/2021
3:57 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
6:35 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2020
3:17 PM
Corvus Pharmaceuticals (Issuer)
Jones William Benton (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:17 PM
Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:16 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:15 PM
Corvus Pharmaceuticals (Issuer)
Mobasher Mehrdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:05 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
7:00 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
7:15 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2020
3:15 PM
Corvus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2020
3:02 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2020
3:50 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
5:04 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2020
4:05 PM
Corvus Pharmaceuticals (Issuer)
Mitchell Edith P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
4:03 PM
Corvus Pharmaceuticals (Issuer)
Mitchell Edith P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2020
7:30 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2020
5:46 PM
Corvus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2020
5:41 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2020
3:35 PM
Corvus Pharmaceuticals (Issuer)
Novo Holdings A/S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2020
3:29 PM
Corvus Pharmaceuticals (Subject)
Novo Holdings A/S (Filed by)
Form SC 13D/A
07/07/2020
6:17 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
4:28 PM
ADAMS STREET PARTNERS LLC (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:15 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:14 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:13 PM
Corvus Pharmaceuticals (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:11 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:10 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
4:07 PM
CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
7:15 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
3:38 PM
Corvus Pharmaceuticals (Issuer)
Novo Holdings A/S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2020
3:35 PM
Corvus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/17/2020
3:13 PM
Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
03/23/2020
4:31 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:30 PM
CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:29 PM
Corvus Pharmaceuticals (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:29 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:28 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:27 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
4:25 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
4:17 PM
Corvus Pharmaceuticals (Filer)
Form 424B5
03/19/2020
11:15 PM
Corvus Pharmaceuticals (Filer)
Form EFFECT
03/09/2020
4:12 PM
Corvus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/05/2020
3:07 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
3:35 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Corvus Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
1:52 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Corvus Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2020
7:00 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2020
7:00 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
3:16 PM
Corvus Pharmaceuticals (Issuer)
Verner Erik J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:15 PM
Corvus Pharmaceuticals (Issuer)
Mobasher Mehrdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:14 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:13 PM
Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:12 PM
Corvus Pharmaceuticals (Issuer)
Jones William Benton (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
5:30 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
8:00 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
3:02 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2019
3:51 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
4:00 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:59 PM
Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:07 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:56 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Corvus Pharmaceuticals (Subject)
Form SC 13G/A
08/01/2019
3:23 PM
Corvus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:10 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
3:38 PM
Corvus Pharmaceuticals (Subject)
Novo Holdings A/S (Filed by)
Form SC 13D/A
07/25/2019
6:21 PM
Corvus Pharmaceuticals (Issuer)
Novo Holdings A/S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:22 PM
Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
07/01/2019
5:16 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
5:15 PM
Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:09 PM
ADAMS STREET PARTNERS LLC (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:07 PM
Corvus Pharmaceuticals (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:06 PM
Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:05 PM
Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:05 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:05 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:05 PM
CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:00 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:08 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
3:55 PM
Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:12 PM
Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
7:30 AM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:40 PM
Corvus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
This page was last updated on 7/26/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.